Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA - North West England

The public procurement process detailed involves NHS England North West, acting as the buying organisation, planning a market landscaping exercise for Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) services in the North West of England. This tender falls under the health services category and is currently in the planning stage. The exercise aims to gather information rather than inviting competition, with a closing date for submission of the Request for Information by 5:00pm on 22 September 2025.

Potential providers should note the future notice date set for 9 October 2025, as this is not a call for competition but an opportunity to express interest in potential future contracts starting on 1 April 2026, spanning three years with a possible two-year extension. This tender presents growth opportunities for companies specialising in health and hospital services, particularly those with capabilities in advanced medical procedures. Businesses that can collaborate closely with NHS entities and innovate within the healthcare system would be well-placed to benefit.

The procurement method involves an electronic tendering tool which can streamline communication and document submission, offering an efficient process for suppliers familiar with digital platforms. Engaging in this market landscaping exercise allows businesses to position themselves advantageously for future competitive opportunities once the tender notice is published.